Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
Stopped accrual goal met
Conditions
- Genetic Markers
- Cardiac Toxicity
- Breast and Skin Motion
Sponsor
AHS Cancer Control Alberta